Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nanomaterial-based blood-brain-barrier (BBB) crossing strategies
Jinbing Xie, Zheyu Shen, Yasutaka Anraku, et al.
Biomaterials (2019) Vol. 224, pp. 119491-119491
Open Access | Times Cited: 440

Showing 51-75 of 440 citing articles:

Nanomaterials toward the treatment of Alzheimer’s disease: Recent advances and future trends
Huihui Zeng, Yujie Qi, Zheyu Zhang, et al.
Chinese Chemical Letters (2021) Vol. 32, Iss. 6, pp. 1857-1868
Closed Access | Times Cited: 60
BBB-crossing adeno-associated virus vector: An excellent gene delivery tool for CNS disease treatment
Wenli Chen, Shun Yao, Jie Wan, et al.
Journal of Controlled Release (2021) Vol. 333, pp. 129-138
Closed Access | Times Cited: 59
Development of L-carnosine functionalized iron oxide nanoparticles loaded with dexamethasone for simultaneous therapeutic potential of blood brain barrier crossing and ischemic stroke treatment
Xianfeng Lu, Yaohui Zhang, Lixiang Wang, et al.
Drug Delivery (2021) Vol. 28, Iss. 1, pp. 380-389
Open Access | Times Cited: 57
Biodistribution, degradability and clearance of 2D materials for their biomedical applications
Taojian Fan, Li Yan, Shiliang He, et al.
Chemical Society Reviews (2022) Vol. 51, Iss. 18, pp. 7732-7751
Open Access | Times Cited: 51
How Nanoparticles Open the Paracellular Route of Biological Barriers: Mechanisms, Applications, and Prospects
Junrong Wu, Zhenjun Zhu, Wenjing Liu, et al.
ACS Nano (2022) Vol. 16, Iss. 10, pp. 15627-15652
Closed Access | Times Cited: 49
Nanocarrier mediated drug delivery as an impeccable therapeutic approach against Alzheimer’s disease
Rajeev Taliyan, Violina Kakoty, K C Sarathlal, et al.
Journal of Controlled Release (2022) Vol. 343, pp. 528-550
Closed Access | Times Cited: 46
The Relationship Between the Blood-Brain-Barrier and the Central Effects of Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter-2 Inhibitors
Meiyuan Dong, Song Wen, Ligang Zhou
Diabetes Metabolic Syndrome and Obesity (2022) Vol. Volume 15, pp. 2583-2597
Open Access | Times Cited: 46
Overcoming the Blood–Brain Barrier for Gene Therapy via Systemic Administration of GSH‐Responsive Silica Nanocapsules
Yuyuan Wang, Xiuxiu Wang, Ruosen Xie, et al.
Advanced Materials (2022) Vol. 35, Iss. 6
Open Access | Times Cited: 46
Delivering the Promise of Gene Therapy with Nanomedicines in Treating Central Nervous System Diseases
Meihua Luo, Leo Kit Cheung Lee, Bo Peng, et al.
Advanced Science (2022) Vol. 9, Iss. 26
Open Access | Times Cited: 44
Platelet-derived extracellular vesicles ameliorate intervertebral disc degeneration by alleviating mitochondrial dysfunction
Zhanqiu Dai, Chen Xia, Tingxiao Zhao, et al.
Materials Today Bio (2022) Vol. 18, pp. 100512-100512
Open Access | Times Cited: 44
Exploring the role of nanomedicines for the therapeutic approach of central nervous system dysfunction: At a glance
Md. Mominur Rhaman, Md. Rezaul Islam, Shopnil Akash, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 42
Micro‐Nanocarriers Based Drug Delivery Technology for Blood‐Brain Barrier Crossing and Brain Tumor Targeting Therapy
Luyao Wang, Youyuan Shi, Jingzhen Jiang, et al.
Small (2022) Vol. 18, Iss. 45
Closed Access | Times Cited: 42
Engineered nanomaterials that exploit blood-brain barrier dysfunction for delivery to the brain
Jason R. Wu, Yazmin Hernandez, Katelyn Miyasaki, et al.
Advanced Drug Delivery Reviews (2023) Vol. 197, pp. 114820-114820
Open Access | Times Cited: 42
Nanotherapeutic treatment of the invasive glioblastoma tumor microenvironment
Nikhil Pandey, Pavlos Anastasiadis, Christine P. Carney, et al.
Advanced Drug Delivery Reviews (2022) Vol. 188, pp. 114415-114415
Open Access | Times Cited: 41
Recent advances in glioma microenvironment-response nanoplatforms for phototherapy and sonotherapy
Xuemeng Li, Xiaorui Geng, Zhiyi Chen, et al.
Pharmacological Research (2022) Vol. 179, pp. 106218-106218
Closed Access | Times Cited: 40
Recent development of contrast agents for magnetic resonance and multimodal imaging of glioblastoma
Danping Zhuang, Hui-fen Zhang, Genwen Hu, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 40
Exosome-based nanoimmunotherapy targeting TAMs, a promising strategy for glioma
Hong Luo, Hao Zhang, Jinning Mao, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 4
Open Access | Times Cited: 40
Cell-Membrane-Coated Nanoparticles for Targeted Drug Delivery to the Brain for the Treatment of Neurological Diseases
Jianzhuang Li, Yanhao Wei, Chunlin Zhang, et al.
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 621-621
Open Access | Times Cited: 37
Micro/nanosystems for controllable drug delivery to the brain
Mingzhen Tian, Zhichao Ma, Guang‐Zhong Yang
The Innovation (2023) Vol. 5, Iss. 1, pp. 100548-100548
Open Access | Times Cited: 35
FTO-targeted siRNA delivery by MSC-derived exosomes synergistically alleviates dopaminergic neuronal death in Parkinson's disease via m6A-dependent regulation of ATM mRNA
Yan Geng, Xinyi Long, Yuting Zhang, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 32
Intranasal nanotherapeutics for brain targeting and clinical studies in Parkinson's disease
Paramita Saha‐Chaudhuri, Himanshu Kathuria, Murali Monohar Pandey
Journal of Controlled Release (2023) Vol. 358, pp. 293-318
Closed Access | Times Cited: 31
Macrophage–Cancer Hybrid Membrane-Camouflaged Nanoplatforms for HIF-1α Gene Silencing-Enhanced Sonodynamic Therapy of Glioblastoma
Yunxia Li, Ying Liu, Jiaqing Xu, et al.
ACS Applied Materials & Interfaces (2023) Vol. 15, Iss. 26, pp. 31150-31158
Closed Access | Times Cited: 29
Angiopep-2 Modified Exosomes Load Rifampicin with Potential for Treating Central Nervous System Tuberculosis
Han Li, Yinan Ding, Jiayan Huang, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 489-503
Open Access | Times Cited: 28
Role of Nanomedicine-Based Therapeutics in the Treatment of CNS Disorders
Zi-Hua Guo, Saadullah Khattak, Mohd Ahmar Rauf, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 1283-1283
Open Access | Times Cited: 28
Low intensity focused ultrasound: a new prospect for the treatment of Parkinson’s disease
Yunxiao Zhong, Jinchi Liao, X.F. Liu, et al.
Annals of Medicine (2023) Vol. 55, Iss. 2
Open Access | Times Cited: 27

Scroll to top